V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20024793 | 20133094 | 0 | 81 | Palliative (P) | 2018-08-09 | 2018-08-09 | null | 02 | N | NOT MATCHED | 101719495 |
| 20024846 | 20133095 | 1.48 | 73.7 | Palliative (P) | 2020-12-02 | 2020-12-25 | null | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100688949 |
| 20024965 | 20133097 | 1.72 | null | null | null | 2020-09-23 | null | 02 | null | ATEZOLIZUMAB + BEVACIZUMAB | 100806359 |
| 20025051 | 20133098 | 1.74 | null | Palliative (P) | null | 2016-04-20 | LUTETIUM-177 | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 100952866 |
| 20025078 | 20133099 | 1.68 | null | null | 2020-03-04 | 2020-03-31 | null | 02 | null | PEMBROLIZUMAB | 100447533 |
| 20025092 | 20133100 | 1.72 | 69.2 | Palliative (P) | 2019-09-14 | 2019-09-16 | null | 02 | N | CETUXIMAB + ENCORAFENIB | 100309044 |
| 20025132 | 20133101 | 162.5 | 76.5 | Palliative (P) | 2020-12-15 | 2021-05-23 | null | N | N | CAPECITABINE + CISPLATIN + RT | 101203305 |
| 20025267 | 20133103 | null | 73.5 | null | 2019-07-21 | 2019-07-25 | null | N | null | SUNITINIB | 100442947 |
| 20025429 | 20133105 | 1.87 | 54 | null | 2016-10-14 | 2016-10-14 | null | 2 | null | OCTREOTIDE | 100818764 |
| 20025524 | 20133106 | 1.69 | 0 | Palliative (P) | 2021-12-08 | 2021-12-08 | null | N | N | ENZALUTAMIDE | 101477248 |
| 20025565 | 20133107 | 1.66 | 96.8 | null | 2018-01-19 | 2019-02-22 | null | N | null | CISPLATIN | 100263583 |
| 20025660 | 20133108 | 1.77 | 44.6 | Palliative (P) | 2017-11-12 | 2017-12-08 | null | 02 | N | LUTETIUM-177 | 100930545 |
| 20025672 | 20133109 | 1.8 | 71.5 | Neo-adjuvant (N) | 2017-02-24 | 2017-03-10 | null | 2 | N | CAPECITABINE + CETUXIMAB + IRINOTECAN | 100991796 |
| 20025711 | 20133110 | 1.68 | 99.6 | Palliative (P) | null | 2017-03-15 | null | 01 | N | EVEROLIMUS | 100349104 |
| 20025817 | 20133112 | 1.68 | 62.4 | Curative (C) | null | 2019-11-25 | null | N | N | OCTREOTIDE | 100369538 |
| 20025831 | 20133113 | 1.71 | 60.6 | Palliative (P) | 2018-08-15 | 2019-02-08 | null | N | N | SCALOP-2 TRIAL | 101553797 |
| 20025898 | 20133114 | null | 62.15 | Adjuvant (A) | 2018-08-28 | 2018-08-28 | PEMBROLIZUMAB | 02 | Y | PEMBROLIZUMAB | 101688673 |
| 20025906 | 20133115 | 1.69 | 84.3 | Palliative (P) | null | 2015-01-08 | null | 02 | Y | NOT MATCHED | 100171951 |
| 20026118 | 20133117 | null | 0 | null | 2017-10-29 | 2017-11-26 | null | 02 | null | ATEZOLIZUMAB + BEVACIZUMAB | 100781028 |
| 20026155 | 20133118 | 1.68 | 66.8 | Palliative (P) | 2016-07-18 | 2016-08-28 | null | 02 | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101104667 |
| 20026164 | 20133119 | 1.82 | 71.8 | Adjuvant (A) | 2016-01-16 | 2016-02-04 | null | 02 | N | CAPECITABINE + CISPLATIN + RT | 100504666 |
| 20026214 | 20133120 | 1.7 | null | Palliative (P) | 2017-08-06 | 2017-08-15 | null | 02 | null | NOT MATCHED | 100672333 |
| 20026240 | 20133121 | 1.63 | 0 | null | 2018-11-22 | 2018-11-22 | null | 02 | null | OCTREOTIDE | 100404533 |
| 20026284 | 20133122 | 1.6 | 52.3 | null | 2018-12-03 | 2018-12-04 | null | 2 | null | SUNITINIB | 100395560 |
| 20026347 | 20133123 | 1.82 | 56 | null | 2017-05-11 | 2017-10-07 | null | 02 | null | CISPLATIN | 101413019 |
| 20026349 | 20133124 | 1.57 | 102.1 | Palliative (P) | 2016-06-10 | 2016-07-08 | CARBOPLATIN + PACLITAXEL + RT | 02 | N | CARBOPLATIN + PACLITAXEL + RT | 100809230 |
| 20026396 | 20133125 | 1.76 | 81.8 | Curative (C) | null | 2019-03-08 | null | 02 | N | PEMBROLIZUMAB | 101239367 |
| 20026468 | 20133127 | 1.73 | 102.2 | null | null | 2021-08-08 | EVEROLIMUS | 02 | null | EVEROLIMUS | 100554235 |
| 20026492 | 20133128 | 1.6 | null | Palliative (P) | 2021-01-14 | 2021-01-15 | null | N | N | OCTREOTIDE | 101571141 |
| 20026591 | 20133130 | 1.83 | 106 | Curative (C) | null | 2017-10-03 | null | 02 | null | PEMBROLIZUMAB | 100887523 |
| 20026793 | 20133131 | null | null | null | 2017-09-06 | 2017-11-20 | null | 02 | null | CAPECITABINE + CISPLATIN + RT | 100970132 |
| 20026877 | 20133132 | 1.65 | null | null | 2019-01-20 | 2019-04-07 | null | 02 | null | CARBOPLATIN + FLUOROURACIL | 101072588 |
| 20026897 | 20133133 | 1.76 | 68 | 03 | 2018-07-28 | 2021-04-21 | null | 02 | N | CETUXIMAB + ENCORAFENIB | 100045606 |
| 20026900 | 20133134 | 1.69 | 108.5 | null | 2021-03-18 | 2021-04-13 | PEMBROLIZUMAB | 02 | null | PEMBROLIZUMAB | 101461184 |
| 20026925 | 20133135 | 1.67 | 64.85 | null | 2019-02-06 | 2019-02-20 | null | N | N | ATEZOLIZUMAB + BEVACIZUMAB | 100883514 |
| 20027029 | 20133137 | 1.67 | 57 | Curative (C) | 2018-09-12 | 2019-07-24 | null | 02 | N | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100893500 |
| 20027056 | 20133139 | 1.75 | null | Palliative (P) | null | 2018-01-08 | null | 02 | N | SCALOP-2 TRIAL | 101312079 |
| 20027204 | 20133140 | 1.66 | 0 | Palliative (P) | 2016-11-11 | 2016-11-11 | null | 02 | N | EVEROLIMUS | 100131731 |
| 20027248 | 20133141 | 1.57 | 52.6 | Palliative (P) | 2022-03-11 | 2022-04-17 | null | 02 | N | CETUXIMAB + ENCORAFENIB | 101162594 |
| 20027278 | 20133142 | 1.71 | 82.2 | null | null | 2016-06-01 | Capecitabine + Cisplatin + RT | N | null | CAPECITABINE + CISPLATIN + RT | 100900697 |
| 20027355 | 20133145 | 1.8 | 60.4 | null | 2018-03-15 | 2018-04-05 | null | 02 | null | OCTREOTIDE | 101058479 |
| 20027367 | 20133146 | 1.69 | 73.1 | null | 2016-08-22 | 2016-10-22 | null | 02 | null | ENZALUTAMIDE | 101134959 |
| 20027393 | 20133147 | 1.68 | null | null | null | 2019-03-02 | null | 02 | null | CISPLATIN + ETOPOSIDE | 101534294 |
| 20027414 | 20133148 | 1.61 | 60.6 | null | 2020-08-20 | 2020-10-15 | null | 02 | null | ABIRATERONE | 100215552 |
| 20027464 | 20133149 | 1.79 | 56.2 | Palliative (P) | 2019-09-05 | 2019-11-16 | LUTETIUM-177 | 02 | N | ATEZOLIZUMAB + BEVACIZUMAB | 101105047 |
| 20027529 | 20133150 | 1.79 | 70 | Adjuvant (A) | 2019-07-11 | 2019-07-12 | null | 02 | N | CAPECITABINE + CISPLATIN + EPIRUBICIN | 100123364 |
| 20027630 | 20133151 | 1.54 | 94.35 | null | null | 2021-09-10 | null | N | null | CISPLATIN + EPIRUBICIN + FLUOROURACIL | 100371024 |
| 20027656 | 20133152 | 1.68 | null | null | 2018-08-17 | 2018-08-17 | null | N | null | MITOMYCIN INTRAVESICULAR | 100779015 |
| 20027660 | 20133153 | 1.71 | 62.8 | Palliative (P) | 2018-09-06 | 2018-09-22 | null | 02 | N | SCALOP-2 TRIAL | 100406404 |
| 20027753 | 20133154 | 1.63 | null | Palliative (P) | 2016-09-04 | 2016-09-04 | null | null | N | CAPECITABINE + CARBOPLATIN + TRASTUZUMAB | 101810360 |